Explore articles tagged with AI
HRV Pharma is redefining pharma economics by turning regulatory filings (DMFs) into scalable global assets—shifting value from manufacturing to compliance and market access.
HRV Pharma CEO Hari Kiran Chereddi explains why drug development success is now determined before manufacturing, driven by data, predictive analytics, and strategic decision-making.
HRV Pharma CEO Hari Kiran Chereddi shares insights on how platform-driven models are transforming pharma from factory-led systems to intelligent, network-based ecosystems.
HRV Pharma partners with Shodhana Laboratories to accelerate next-generation API development, combining AI-enabled virtual manufacturing with precision chemistry and global regulatory execution.
HRV Pharma (Group) has been recognised at the ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support, highlighting its leadership in compliant, agile, and globally integrated pharmaceutical operations.
HRV Pharma’s capital‑efficient virtual pharmaceutical model is helping address America’s drug shortage crisis by linking underutilized global manufacturing capacity with regulatory strength to ensure consistent API supply.
Workplace safety in pharma can no longer be a checklist exercise. This blog shares how HRV Pharma, led by MD & CEO Hari Kiran Chereddi, is using virtual manufacturing networks, stronger EHS governance, and ESG‑aligned practices to raise safety standards across partner sites and protect people, reputation, and India’s role as the world’s pharmacy.
Pharmaceutical Commerce features HRV Pharma on how AI-validated digital backbones speed regulatory reviews, improve supplier onboarding, and make forecasting more reliable.